Literature DB >> 7731716

Effects of heterozygosity for the Rb-1t19neo allele in the mouse.

D J Harrison1, M L Hooper, J F Armstrong, A R Clarke.   

Abstract

We describe the pathology of a cohort of 80 mice heterozygous for an inactive allele of the Rb-1 tumour suppressor gene. The majority of these mice developed locally invasive tumours, arising from the pituitary gland. The time of onset of overt signs of disease in mice known to have inherited their mutant allele paternally shows a small but statistically significant shift to the lower end of the spectrum, suggesting that tumorigenesis is influenced by gametic imprinting. In situ hybridisation analysis demonstrates the presence in the tumours of pro-opiomelanocortin mRNA, which is normally found both in corticotroph and melanotroph cells. Mice within this cohort also develop systemic defects. Most notably, there is increased siderosis in the spleen indicating the possibility of an abnormality in red blood cell turnover. This is consistent with the abnormalities of erythropoiesis described previously in homozygous Rb-1-deficient mice. In addition, a proportion of mice developed liver steatosis, probably representing the end organ effects of hormonal imbalance as a direct consequence of tumour presence. A significant proportion showed C cell hyperplasia in the thyroid. The spectrum of pathology in mice differs from that in the human but does provide a useful model of site-specific tumour predisposition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731716

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.

Authors:  Chiaki Takahashi; Bernardo Contreras; Roderick T Bronson; Massimo Loda; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

2.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

Review 3.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

4.  pRb-Independent growth arrest and transcriptional regulation of E2F target genes.

Authors:  Michael T McCabe; Odinaka J Azih; Mark L Day
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

5.  Genomic imprinting of the human serotonin-receptor (HTR2) gene involved in development of retinoblastoma.

Authors:  M V Kato; T Shimizu; M Nagayoshi; A Kaneko; M S Sasaki; Y Ikawa
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

6.  ARF mutation accelerates pituitary tumor development in Rb+/- mice.

Authors:  Kenneth Y Tsai; David MacPherson; Douglas A Rubinson; Alexander Yu Nikitin; Roderick Bronson; Kim L Mercer; Denise Crowley; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 7.  Lessons from the p53 mutant mouse.

Authors:  T Jacks
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 8.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

9.  E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.

Authors:  Cuiqi Zhou; Kolja Wawrowsky; Serguei Bannykh; Shiri Gutman; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-10-16

10.  Rb and N-ras function together to control differentiation in the mouse.

Authors:  Chiaki Takahashi; Roderick T Bronson; Merav Socolovsky; Bernardo Contreras; Kwang Youl Lee; Tyler Jacks; Makoto Noda; Raju Kucherlapati; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.